Serraino D, Pezzotti P, Dorrucci M, Alliegro M B, Sinicco A, Rezza G
Epidemiology Unit, Centro di Riferimento Oncologico, Aviano, Italy.
Cancer. 1997 Mar 1;79(5):1004-8. doi: 10.1002/(sici)1097-0142(19970301)79:5<1004::aid-cncr17>3.0.co;2-5.
In addition to Kaposi's sarcoma and non-Hodgkin's lymphomas, it has been postulated that human immunodeficiency virus (HIV) infection may increase the risk of other cancers. The aim of the current study was to compare incidence rates of cancer among individuals who seroconverted for HIV infection with the rates in the general population of Italy.
This study is part of an ongoing cohort investigation conducted by the HIV Italian Seroconversion Study Group. The study has enrolled 1255 individuals (906 males and 349 females) between the ages of 20 and 49 years who are at risk for HIV infection and have had a documented negative HIV test followed by a positive test. For each individual, the midpoint in time between the negative and positive tests was used to estimate the seroconversion date. The person-years at risk for cancer were then computed from the midpoint date to the last follow-up date or to death, and the number of cases of cancer observed in the cohort was compared with the expected number, based on rates among the general population of the same age and gender. Standardized incidence ratios (SIR) and 95% confidence intervals (CI) were computed.
A total of 58 cases of cancer were observed in the cohort. In comparison with rates in the general population, Kaposi's sarcoma was 1051 times more frequent, and non-Hodgkin's lymphomas were 157 times more frequent. Hodgkin's disease was observed in 3 men (i.e., 38 times more often in the cohort of HIV seroconverters [95% CI, 8-111]), in particular among homosexual men (SIR = 103). One woman developed stomach carcinoma.
The findings of the current incidence study are in agreement with previous studies showing excesses of Kaposi's sarcoma and non-Hodgkin's lymphomas in HIV-positive individuals. In addition, the findings suggest an association of HIV infection with Hodgkin's disease. Whether Hodgkin's disease in HIV-infected individuals should be considered an AIDS-defining illness is a question that is worthy of attention.
除卡波西肉瘤和非霍奇金淋巴瘤外,有假设认为人类免疫缺陷病毒(HIV)感染可能会增加患其他癌症的风险。本研究的目的是比较HIV感染血清转化者与意大利普通人群的癌症发病率。
本研究是意大利HIV血清转化研究组正在进行的队列研究的一部分。该研究纳入了1255名年龄在20至49岁之间有HIV感染风险且有记录显示HIV检测从阴性转为阳性的个体(906名男性和349名女性)。对于每个个体,阴性和阳性检测之间的时间中点用于估计血清转化日期。然后从该中点日期到最后随访日期或死亡日期计算患癌的人年数,并将队列中观察到的癌症病例数与基于同年龄和性别的普通人群发病率的预期病例数进行比较。计算标准化发病率(SIR)和95%置信区间(CI)。
队列中总共观察到58例癌症病例。与普通人群的发病率相比,卡波西肉瘤的发病率高1051倍,非霍奇金淋巴瘤的发病率高157倍。在3名男性中观察到霍奇金病(即HIV血清转化者队列中的发病率高38倍[95%CI,8 - 111]),特别是在同性恋男性中(SIR = 103)。一名女性患了胃癌。
当前发病率研究的结果与先前的研究一致,这些研究表明HIV阳性个体中卡波西肉瘤和非霍奇金淋巴瘤的发病率过高。此外,研究结果表明HIV感染与霍奇金病之间存在关联。HIV感染者中的霍奇金病是否应被视为艾滋病定义疾病是一个值得关注的问题。